Your browser doesn't support javascript.
loading
Perspectives in melanoma: meeting report from the "Melanoma Bridge" (December 5th-7th, 2019, Naples, Italy).
Ascierto, Paolo A; Puzanov, Igor; Agarwala, Sanjiv S; Blank, Christian; Carvajal, Richard D; Demaria, Sandra; Dummer, Reinhard; Ernstoff, Marc; Ferrone, Soldano; Fox, Bernard A; Gajewski, Thomas F; Garbe, Claus; Hwu, Patrick; Lo, Roger S; Long, Georgina V; Luke, Jason J; Osman, Iman; Postow, Michael A; Sullivan, Ryan J; Taube, Janis M; Trinchieri, Giorgio; Zarour, Hassane M; Caracò, Corrado; Thurin, Magdalena.
Afiliação
  • Ascierto PA; Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. paolo.ascierto@gmail.com.
  • Puzanov I; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Agarwala SS; Temple University School of Medicine, Philadelphia, PA, USA.
  • Blank C; Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Carvajal RD; Columbia University Irving Medical Center, Herbert Irving Comprehensive Cancer Center, New York, NY, USA.
  • Demaria S; Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA.
  • Dummer R; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
  • Ernstoff M; Department of Dermatology, University of Zurich Hospital, Zurich, Switzerland.
  • Ferrone S; Roswell Park Comprehensive Cancer Center, Jacobs School of Medicine and Biomedical Sciences, State University, Buffalo, NY, USA.
  • Fox BA; Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Gajewski TF; Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Cancer Institute, Portland, OR, USA.
  • Garbe C; Department of Pathology, University of Chicago, Chicago, IL, USA.
  • Hwu P; Department of Medicine (Section of Haematology/Oncology), University of Chicago, Chicago, IL, USA.
  • Lo RS; Center for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tübingen, Germany.
  • Long GV; Department of Melanoma Medical Oncology, Division of Cancer Medicine, Anderson Cancer Center, Houston, TX, USA.
  • Luke JJ; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
  • Osman I; Melanoma Institute Australia, The University of Sydney and Royal North Shore and Mater Hospitals, Sydney, Australia.
  • Postow MA; Medicine University of Chicago, Chicago, IL, USA.
  • Sullivan RJ; The Interdisciplinary Melanoma Program, New York University Langone Medical Center, NYU Grossman Medical School, New York, NY, USA.
  • Taube JM; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA.
  • Trinchieri G; Melanoma Program, Mass General Cancer Center, Boston, MA, USA.
  • Zarour HM; Division of Dermatopathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Caracò C; Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Thurin M; Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
J Transl Med ; 18(1): 346, 2020 09 07.
Article em En | MEDLINE | ID: mdl-32894202

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia / Melanoma Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: J Transl Med Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia / Melanoma Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: J Transl Med Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Itália